Details of the Drug Reposition

General Information of This Drug (ID: DMU6TG7)

Drug Name
XMT-1592   DMU6TG7
Drug Type
Antibody drug conjugate

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Phase 1/2 [1]
Ovarian cancer DISZJHAP 2C73 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04396340) First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b. U.S. National Institutes of Health.